Business
LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options
Investments in pharmacy benefits infrastructure, in-home lab services and new treatment options expand platform capabilities and are estimated to increase
About this update from Lifemd, Inc.
[{"type":"text","content":"Investments in pharmacy benefits infrastructure, in-home lab services and new treatment options expand platform capabilities and are estimated to increase LifeMD’s addressable weight loss market by 15%\nNEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc.® (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced significant enhancements to its weight management program, underscoring the company’s commitment to expanding patient access and improving the quality and comprehensiveness of care available on its virtual care platform. The investments include a new and improved platform and partnership for in-home lab collection, technology enhancements for prior authorization and pharmacy benefits infrastructure, and the launch of personalized prescription treatment options. These advancements further establish LifeMD as a leader in the rapidly growing market for virtual healthcare. As part of its commitment to increasing access to branded prescription GLP-1 medications, LifeMD has developed and is launching a real-time electronic benefit verification program that allows patients to check pharmacy benefits verification before enrolling in a LifeMD virtual care program. Additionally, LifeMD has partnered with an AI-powered platform that optimizes prior authorization submissions and appeals to improve approval rates for patients. These enhancements are designed to minimize delays in care, reduce barriers to accessing brand-name medications, and ensure that a broader range of patients can benefit from LifeMD’s offerings. “Our No. 1 objective for 2024 is to deliver on LifeMD’s commitment to build the most comprehensive and accessible virtual care offering for weight management in the United States,” said Justin Schreiber, Chairman and CEO of LifeMD. “Our latest investments in in-home lab services and our pharmacy benefits verification infrastructure – combined with our past and present investments in our medical benefits infrastructure, pharmacy, affiliated provider group, AI-enhanced workflows and technology – are highly differentiating for LifeMD and help us break down the barriers that prevent many Americans from accessing lifechanging healthcare.” “Importantly, we are already benefitting from these investments with more than 38% of patients over the past 30 days who provided us with their insurance inf...